---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-017895"
form_type: "8-K"
ticker: "EMMA"
cik: "0000822370"
company_name: "Emmaus Life Sciences, Inc."
filed_at: "2023-03-07T23:59:59+00:00"
generated_at: "2026-06-18T10:52:03.742004+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Emmaus Life Sciences issues convertible note to director for $1M and warrants for services

## Summary
- Director loaned $1M via convertible note due demand after 1 yr, 10% interest, convertible at $0.50/share into 2M shares.
- Two individuals received warrants for 250K shares each at $0.50/share for consulting services.
- Consulting firm received 5-yr warrant for 500K shares at $0.47/share for services.
- Total shares underlying instruments represent ~6% of pre-issuance common stock.
- Securities issued without registration under Section 4(a)(2) exemption.

## SEC filing metadata
- accession: 0001213900-23-017895
- form_type: 8-K
- ticker: EMMA
- cik: 0000822370
- company_name: Emmaus Life Sciences, Inc.
- filed_at: 2023-03-07T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/822370/000121390023017895/0001213900-23-017895-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/822370/000121390023017895/ea174679-8k_emmauslife.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-017895
- JSON: https://secwatch.observer/filing/0001213900-23-017895.json
- Plain text: https://secwatch.observer/filing/0001213900-23-017895.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.